LAUSR

17 MavinkurveGroothuis AMC, Weijers G, GrootLoonen J, et al. Interobserver, intraobserver and intrapatient reliability scores of myocardial strain imaging with 2D echocardiography in patients treated with anthracyclines. Ultrasound Med Biol 2009;35:697–704. 18 Thavendiranathan P, Poulin F, Lim KD, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 2014;63:2751–68. 19 Agha H, Shalaby L, Attia W, et al. Early ventricular dysfunction after anthracycline chemotherapy in children. Pediatr Cardiol 2016;37:537–44. 20 Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur J Heart Fail 2017;19:9–42. 21 Yingchoncharoen T, Agarwal S, Popović ZB, et al. Normal ranges of left ventricular strain: a metaanalysis. J Am Soc Echocardiogr 2013;26:185–91. 22 Sadurska E. Current views on anthracycline cardiotoxicity in childhood cancer survivors. Pediatr Cardiol 2015;36:1112–9. 23 MavinkurveGroothuis AMC, Marcus KA, Pourier M, et al. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (all): a prospective study. Eur Heart J Cardiovasc Imaging 2013;14:562–9. 24 Paraskevaidis IA, Makavos G, Tsirigotis P, et al. Deformation analysis of myocardial layers detects early cardiac dysfunction after chemotherapy in bone marrow transplantation patients: a continuous and additive cardiotoxicity process. J Am Soc Echocardiogr 2017;30:1091–102. 25 Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009;15:1628–33. 26 Morandi P, Ruffini PA, Benvenuto GM, et al. Cardiac toxicity of highdose chemotherapy. Bone Marrow Transplant 2005;35:323–34. 27 Van Besien K, Devine S, Wickrema A, et al. Regimenrelated toxicity after fludarabinemelphalan conditioning: a prospective study of 31 patients with hematologic malignancies. Bone Marrow Transplant 2003;32:471–6. 28 Boczar KE, Aseyev O, Sulpher J, et al. Right heart function deteriorates in breast cancer patients undergoing anthracyclinebased chemotherapy. Echo Res Pract 2016;3:79–84. 29 YağciKüpeli B, Varan A, Yorgun H, et al. Tissue Doppler and myocardial deformation imaging to detect myocardial dysfunction in pediatric cancer patients treated with high doses of anthracyclines. Asia Pac J Clin Oncol 2012;8:368–74. 30 Selvakumar D, Brown P, Geenty P, et al. Comparative assessments of left and right ventricular function by twodimensional, contrast enhanced and threedimensional echocardiography with gated heart pool scans in patients following myocardial infarction. Am J Cardiol 2020;134:14–23. 31 Galderisi M, Cosyns B, Edvardsen T, et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 2017;18:1301–10.